ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 8 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $95 | -100.0% | 262,508 | -28.2% | 0.00% | – |
| Q3 2022 | $219,000 | -7.2% | 365,800 | -23.1% | 0.00% | – |
| Q2 2022 | $236,000 | +268.8% | 475,896 | +574.1% | 0.00% | – |
| Q1 2022 | $64,000 | -69.7% | 70,600 | -40.5% | 0.00% | – |
| Q3 2021 | $211,000 | -82.2% | 118,558 | -67.0% | 0.00% | -100.0% |
| Q2 2021 | $1,187,000 | +37.1% | 359,649 | +39.1% | 0.00% | 0.0% |
| Q1 2021 | $866,000 | +45.5% | 258,467 | -20.5% | 0.00% | 0.0% |
| Q4 2020 | $595,000 | +302.0% | 324,918 | +317.1% | 0.00% | – |
| Q3 2020 | $148,000 | -42.2% | 77,900 | -39.2% | 0.00% | – |
| Q2 2020 | $256,000 | +232.5% | 128,050 | +70.4% | 0.00% | – |
| Q1 2020 | $77,000 | +120.0% | 75,163 | +332.0% | 0.00% | – |
| Q4 2019 | $35,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,194,070 | $3,940,000 | 2.71% |
| Sio Capital Management, LLC | 1,488,508 | $4,912,000 | 1.22% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $8,298,000 | 0.85% |
| KNOTT DAVID M | 478,186 | $1,578,000 | 0.56% |
| Logos Global Management LP | 2,000,000 | $6,600,000 | 0.56% |
| DAFNA Capital Management LLC | 677,500 | $2,236,000 | 0.47% |
| Vivo Capital, LLC | 2,840,909 | $9,375,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 765,276 | $2,525,000 | 0.36% |
| MYDA Advisors LLC | 211,165 | $697,000 | 0.17% |
| Parkman Healthcare Partners LLC | 225,881 | $745,000 | 0.16% |